<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Ceftriaxon.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:44 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Ceftriaxon_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Ceftriaxon_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Ceftriaxon_files/filelist.xml">
<title>CEFTRIAXON</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>5</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2006-08-08T14:03:00Z</o:Created>
  <o:LastSaved>2006-08-09T05:20:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1468</o:Words>
  <o:Characters>8368</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>69</o:Lines>
  <o:Paragraphs>19</o:Paragraphs>
  <o:CharactersWithSpaces>9817</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>CEFTRIAXON<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: Ceftriaxone.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> J01D A13.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Kháng sinh
cephalosporin th&#7871; h&#7879; 3. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm
l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>L&#7885; 250 mg, 500 mg, 1 g d&#7841;ng b&#7897;t &#273;&#7875; tiêm b&#7855;p
ho&#7863;c t&#297;nh m&#7841;ch, có &#7889;ng dung môi kèm theo. Dung môi
&#273;&#7875; tiêm b&#7855;p ch&#7913;a 1% lidocain. Dung môi tiêm t&#297;nh m&#7841;ch
ch&#7913;a n&#432;&#7899;c c&#7845;t vô khu&#7849;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>L&#7885; 2 g d&#7841;ng b&#7897;t &#273;&#7875; tiêm truy&#7873;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ceftriaxon là m&#7897;t cephalosporin th&#7871; h&#7879; 3 có ho&#7841;t
ph&#7893; r&#7897;ng, &#273;&#432;&#7907;c s&#7917; d&#7909;ng d&#432;&#7899;i
d&#7841;ng tiêm. Tác d&#7909;ng di&#7879;t khu&#7849;n c&#7911;a nó là do &#7913;c
ch&#7871; s&#7921; t&#7893;ng h&#7907;p thành t&#7871; bào vi khu&#7849;n.
Ceftriaxon b&#7873;n v&#7919;ng v&#7899;i &#273;a s&#7889; các beta lactamase
(penicilinase và cephalosporinase) c&#7911;a các vi khu&#7849;n Gram âm và Gram
d&#432;&#417;ng. Ceftriaxon th&#432;&#7901;ng có tác d&#7909;ng in vitro và
trong nhi&#7877;m khu&#7849;n lâm sàng &#273;&#7889;i v&#7899;i các vi khu&#7849;n
d&#432;&#7899;i &#273;ây.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gram âm &#432;a khí: <i>Acinetobacter calcoaceticus, Enterobacter
aerogenes, Enterobacter cloacae, Escherichia coli, Haemophilus influenzae </i>(bao
g&#7891;m các ch&#7911;ng kháng ampicilin) <i>Haemophilus parainfluenzae,
Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Neisseria
gonorrhoeae, Neisseria meningitidis, Proteus mirabilis</i>, <i>Proteus
vulgaris, Serratia marcescens.<o:p></o:p></i></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ceftriaxon c&#361;ng có tác d&#7909;ng &#273;&#7889;i v&#7899;i nhi&#7873;u
ch&#7911;ng <i>Pseudomonas aeruginosa</i>.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ghi chú</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: nhi&#7873;u ch&#7911;ng c&#7911;a
các vi khu&#7849;n nêu trên có tính &#273;a kháng v&#7899;i nhi&#7873;u kháng
sinh khác nh&#432; penicilin, cephalosporin và aminoglycosid nh&#432;ng nh&#7841;y
c&#7843;m v&#7899;i ceftriaxon.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:.1pt'>Gram d&#432;&#417;ng &#432;a khí: <i>Staphylococcus
aureus</i> (bao g&#7891;m c&#7843; ch&#7911;ng sinh penicilinase), <i>Staphylococcus
epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes,</i> <i>Streptococcus</i>
nhóm viridans</span><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ghi chú:</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> <i>Staphylococcus</i> kháng
methicilin c&#361;ng kháng v&#7899;i các cephalosporin bao g&#7891;m c&#7843; ceftriaxon.
Ða s&#7889; các ch&#7911;ng thu&#7897;c <i>Streptococcus </i>nhóm D và <i>Enterococcus</i>,
thí d&#7909; <i>Enterococcus faccalis</i> &#273;&#7873;u kháng v&#7899;i
ceftriaxon.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>K&#7925; khí: <i>Bacteroides fragilis</i>, <i>Clostridium </i>các
loài, các loài <i>Peptostreptococcus</i><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ghi chú:</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> Ða s&#7889; các ch&#7911;ng <i>C.
difficile</i> &#273;&#7873;u kháng v&#7899;i ceftriaxon. Ceftriaxon
&#273;&#432;&#7907;c ch&#7913;ng minh <i>in vitro</i> có tác d&#7909;ng ch&#7889;ng
&#273;a s&#7889; các ch&#7911;ng c&#7911;a các vi khu&#7849;n sau &#273;ây,
nh&#432;ng ý ngh&#297;a v&#7873; m&#7863;t lâm sàng ch&#432;a bi&#7871;t rõ.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gram âm hi&#7871;u khí: <i>Citrobacter diversus, Citrobacter freundii,
</i>các loài <i>Providencia</i> (bao g&#7891;m <i>Providencia rettgeri</i>) các
loài <i>Salmonella</i> (bao g&#7891;m <i>S. typhi</i>), các loài <i>Shigella</i>.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gram d&#432;&#417;ng &#432;a khí: <i>Streptococcus agalactiae.</i><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>K&#7925; khí: <i>Bacteroides bivius</i>, <i>Bacteroides
melaninogenicus.</i><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ceftriaxon không h&#7845;p thu qua &#273;&#432;&#7901;ng tiêu hóa, do
v&#7853;y &#273;&#432;&#7907;c s&#7917; d&#7909;ng qua &#273;&#432;&#7901;ng
tiêm t&#297;nh m&#7841;ch ho&#7863;c tiêm b&#7855;p. Sinh kh&#7843; d&#7909;ng
sau khi tiêm b&#7855;p là 100%.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>N&#7891;ng &#273;&#7897; huy&#7871;t t&#432;&#417;ng t&#7889;i &#273;a
&#273;&#7841;t &#273;&#432;&#7907;c do tiêm b&#7855;p li&#7873;u 1,0 g
ceftriaxon là kho&#7843;ng 81 mg/lít sau 2 - 3 gi&#7901;. Ceftriaxon phân b&#7889;
r&#7897;ng kh&#7855;p trong các mô và d&#7883;ch c&#417; th&#7875;. Kho&#7843;ng
85 - 90% ceftriaxon g&#7855;n v&#7899;i protein huy&#7871;t t&#432;&#417;ng và
tùy thu&#7897;c vào n&#7891;ng &#273;&#7897; thu&#7889;c trong huy&#7871;t
t&#432;&#417;ng. Th&#7875; tích phân b&#7889; c&#7911;a ceftriaxon là 3 - 13
lít và &#273;&#7897; thanh th&#7843;i huy&#7871;t t&#432;&#417;ng là 10 - 22
ml/phút, trong khi thanh th&#7843;i th&#7853;n bình th&#432;&#7901;ng là 5 - <span
style='letter-spacing:-.1pt'>12 ml/phút. N&#7917;a &#273;&#7901;i trong huy&#7871;t
t&#432;&#417;ng x&#7845;p x&#7881; 8 gi&#7901;. &#7903; ng&#432;&#7901;i b&#7879;nh
trên 75 tu&#7893;i, n&#7917;a &#273;&#7901;i dài h&#417;n, trung bình là 14 gi&#7901;.</span><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c &#273;i qua nhau thai và bài ti&#7871;t ra s&#7919;a v&#7899;i
n&#7891;ng &#273;&#7897; th&#7845;p. T&#7889;c &#273;&#7897; &#273;ào th&#7843;i
có th&#7875; gi&#7843;m &#7903; ng&#432;&#7901;i b&#7879;nh th&#7849;m phân.
Kho&#7843;ng 40 - 65% li&#7873;u thu&#7889;c tiêm vào &#273;&#432;&#7907;c bài
ti&#7871;t d&#432;&#7899;i d&#7841;ng không &#273;&#7893;i qua th&#7853;n, ph&#7847;n
còn l&#7841;i qua m&#7853;t r&#7891;i cu&#7889;i cùng qua phân d&#432;&#7899;i
d&#7841;ng không bi&#7871;n &#273;&#7893;i ho&#7863;c b&#7883; chuy&#7875;n hóa
b&#7903;i h&#7879; vi sinh &#273;&#432;&#7901;ng ru&#7897;t thành nh&#7919;ng h&#7907;p
ch&#7845;t không còn ho&#7841;t tính kháng sinh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trong tr&#432;&#7901;ng h&#7907;p suy gi&#7843;m ch&#7913;c n&#259;ng
gan, s&#7921; bài ti&#7871;t qua th&#7853;n &#273;&#432;&#7907;c t&#259;ng lên
và ng&#432;&#7907;c l&#7841;i n&#7871;u ch&#7913;c n&#259;ng th&#7853;n b&#7883;
gi&#7843;m thì s&#7921; bài ti&#7871;t qua m&#7853;t t&#259;ng lên. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ceftriaxon ch&#7881; nên dùng &#273;i&#7873;u tr&#7883; các b&#7879;nh
nhi&#7877;m khu&#7849;n n&#7863;ng. C&#7847;n h&#7871;t s&#7913;c h&#7841;n ch&#7871;
s&#7917; d&#7909;ng các cephalosporin th&#7871; h&#7879; 3.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các nhi&#7877;m khu&#7849;n n&#7863;ng do các vi khu&#7849;n nh&#7841;y
c&#7843;m v&#7899;i ceftriaxon k&#7875; c&#7843; viêm màng não, tr&#7915; th&#7875;
do <i>Listeria monocytogenes</i>, b&#7879;nh Lyme, nhi&#7877;m khu&#7849;n
&#273;&#432;&#7901;ng ti&#7871;t ni&#7879;u (g&#7891;m c&#7843; viêm b&#7875;
th&#7853;n), viêm ph&#7893;i, l&#7853;u, th&#432;&#417;ng hàn, giang mai, nhi&#7877;m
khu&#7849;n huy&#7871;t, nhi&#7877;m khu&#7849;n x&#432;&#417;ng và kh&#7899;p,
nhi&#7877;m khu&#7849;n da.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#7921; phòng nhi&#7877;m khu&#7849;n trong các ph&#7851;u thu&#7853;t,
n&#7897;i soi can thi&#7879;p (nh&#432; ph&#7851;u thu&#7853;t âm &#273;&#7841;o
ho&#7863;c &#7893; b&#7909;ng).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>M&#7851;n c&#7843;m v&#7899;i cephalosporin, ti&#7873;n s&#7917; có ph&#7843;n
&#7913;ng ph&#7843;n v&#7879; v&#7899;i penicilin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>V&#7899;i d&#7841;ng thu&#7889;c tiêm b&#7855;p th&#7883;t: M&#7851;n
c&#7843;m v&#7899;i lidocain, không dùng cho tr&#7867; d&#432;&#7899;i 30
tháng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tr&#432;&#7899;c khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883;
b&#7857;ng ceftriaxon, ph&#7843;i &#273;i&#7873;u tra k&#7929; v&#7873; ti&#7873;n
s&#7917; d&#7883; &#7913;ng c&#7911;a ng&#432;&#7901;i b&#7879;nh v&#7899;i
cephalosporin, penicilin ho&#7863;c thu&#7889;c khác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có nguy c&#417; d&#7883; &#7913;ng chéo &#7903; nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh d&#7883; &#7913;ng v&#7899;i penicilin. Trong nh&#7919;ng tr&#432;&#7901;ng
h&#7907;p suy th&#7853;n, ph&#7843;i th&#7853;n tr&#7885;ng xem xét li&#7873;u
dùng. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>V&#7899;i ng&#432;&#7901;i b&#7879;nh b&#7883; suy gi&#7843;m c&#7843;
ch&#7913;c n&#259;ng th&#7853;n và gan &#273;áng k&#7875;, li&#7873;u
ceftriaxon không nên v&#432;&#7907;t quá 2 g/ngày n&#7871;u không theo dõi
&#273;&#432;&#7907;c ch&#7863;t ch&#7869; n&#7891;ng &#273;&#7897; thu&#7889;c
trong huy&#7871;t t&#432;&#417;ng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Kinh nghi&#7879;m lâm sàng trong &#273;i&#7873;u tr&#7883; cho ng&#432;&#7901;i
mang thai còn h&#7841;n ch&#7871;. S&#7889; li&#7879;u nghiên c&#7913;u trên
súc v&#7853;t ch&#432;a th&#7845;y &#273;&#7897;c v&#7899;i bào thai. Tuy v&#7853;y
ch&#7881; nên dùng thu&#7889;c cho ng&#432;&#7901;i mang thai khi th&#7853;t c&#7847;n
thi&#7871;t.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:.1pt'>Thu&#7889;c bài ti&#7871;t qua s&#7919;a &#7903; n&#7891;ng
&#273;&#7897; th&#7845;p, c&#7847;n th&#7853;n tr&#7885;ng khi dùng thu&#7889;c
cho ng&#432;&#7901;i &#273;ang cho con bú.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Nói chung, ceftriaxon dung n&#7841;p t&#7889;t.
Kho&#7843;ng 8% s&#7889; ng&#432;&#7901;i b&#7879;nh &#273;&#432;&#7907;c
&#273;i&#7873;u tr&#7883; có tác d&#7909;ng ph&#7909;, t&#7847;n xu&#7845;t ph&#7909;
thu&#7897;c vào li&#7873;u và th&#7901;i gian &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt;1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: &#7880;a ch&#7843;y.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Da: Ph&#7843;n &#7913;ng da, ng&#7913;a, n&#7893;i
ban.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>ít g&#7863;p, 1/100 &gt; ADR
&gt;1/1000<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Toàn thân: S&#7889;t, viêm t&#297;nh m&#7841;ch,
phù.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Máu: T&#259;ng b&#7841;ch c&#7847;u &#432;a
eosin, gi&#7843;m ti&#7875;u c&#7847;u, gi&#7843;m b&#7841;ch c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Da: N&#7893;i mày &#273;ay.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Hi&#7871;m g&#7863;p, ADR &lt; 1/1000<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Toàn thân: Ðau &#273;&#7847;u, chóng m&#7863;t,
ph&#7843;n v&#7879;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Máu: Thi&#7871;u máu, m&#7845;t b&#7841;ch c&#7847;u
h&#7841;t, r&#7889;i lo&#7841;n &#273;ông máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Tiêu hóa: Viêm &#273;&#7841;i tràng có màng gi&#7843;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Da: Ban &#273;&#7887; &#273;a d&#7841;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ti&#7871;t ni&#7879;u - sinh d&#7909;c: Ti&#7875;u
ti&#7879;n ra máu, t&#259;ng creatinin huy&#7871;t thanh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>T&#259;ng nh&#7845;t th&#7901;i các enzym gan
trong khi &#273;i&#7873;u tr&#7883; b&#7857;ng ceftriaxon. Sau khi &#273;i&#7873;u
tr&#7883; v&#7899;i các thu&#7889;c kháng sinh th&#432;&#7901;ng &#7843;nh
h&#432;&#7903;ng &#273;&#7871;n h&#7879; vi khu&#7849;n &#273;&#432;&#7901;ng
ru&#7897;t và gây t&#259;ng phát tri&#7875;n các n&#7845;m, men ho&#7863;c nh&#7919;ng
vi khu&#7849;n khác. Tr&#432;&#7901;ng h&#7907;p viêm &#273;&#7841;i tràng có
liên quan &#273;&#7871;n kháng sinh th&#432;&#7901;ng do <i>C. difficile</i> và
c&#7847;n &#273;&#432;&#7907;c xem xét trong tr&#432;&#7901;ng h&#7907;p &#7881;a
ch&#7843;y.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Siêu âm túi m&#7853;t &#7903; ng&#432;&#7901;i b&#7879;nh
&#273;i&#7873;u tr&#7883; b&#7857;ng ceftriaxon, có th&#7875; có hình m&#7901;
do t&#7841;o t&#7911;a c&#7911;a mu&#7889;i ceftriaxon calci. Khi ng&#7915;ng
&#273;i&#7873;u tr&#7883; ceftriaxon, t&#7911;a này l&#7841;i h&#7871;t. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ph&#7843;n &#7913;ng khác: Khi dùng li&#7873;u
cao kéo dài có th&#7875; th&#7845;y trên siêu âm hình &#7843;nh bùn ho&#7863;c
gi&#7843; s&#7887;i &#273;&#432;&#7901;ng m&#7853;t do &#273;&#7885;ng mu&#7889;i
calci c&#7911;a ceftriaxon, hình &#7843;nh này s&#7869; m&#7845;t &#273;i khi
ng&#7915;ng thu&#7889;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt;mso-ansi-language:DE'>Ceftriaxon có th&#7875; tách
bilirubin ra kh&#7887;i albumin huy&#7871;t thanh, làm t&#259;ng n&#7891;ng
&#273;&#7897; bilirubin t&#7921; do, &#273;e d&#7885;a nhi&#7877;m &#273;&#7897;c
th&#7847;n kinh trung &#432;&#417;ng. Vì v&#7853;y nên tránh dùng thu&#7889;c
này cho tr&#7867; s&#417; sinh b&#7883; vàng da, nh&#7845;t là tr&#7867;
s&#417; sinh thi&#7871;u tháng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Có th&#7875; x&#7843;y ra ph&#7843;n &#7913;ng
Coombs d&#432;&#417;ng tính không có tan máu, th&#7917; nghi&#7879;m galactose
- huy&#7871;t và glucose - ni&#7879;u có th&#7875; d&#432;&#417;ng tính gi&#7843;
do ceftriaxon.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Li&#7873;u dùng và cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ceftriaxon có th&#7875; tiêm t&#297;nh m&#7841;ch
ho&#7863;c tiêm b&#7855;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Ng&#432;&#7901;i l&#7899;n</span></i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>: Li&#7873;u th&#432;&#7901;ng dùng m&#7895;i
ngày t&#7915; 1 &#273;&#7871;n 2 g, tiêm m&#7897;t l&#7847;n (ho&#7863;c chia
&#273;&#7873;u làm hai l&#7847;n). Tr&#432;&#7901;ng h&#7907;p n&#7863;ng, có
th&#7875; lên t&#7899;i 4 g. Ð&#7875; d&#7921; phòng nhi&#7877;m khu&#7849;n
trong ph&#7851;u thu&#7853;t, tiêm t&#297;nh m&#7841;ch m&#7897;t li&#7873;u
duy nh&#7845;t 1 g t&#7915; 0,5 - 2 gi&#7901; tr&#432;&#7899;c khi m&#7893;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Tr&#7867; em</span></i><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>: Li&#7873;u dùng m&#7895;i ngày 50 - 75 mg/kg,
tiêm m&#7897;t l&#7847;n ho&#7863;c chia &#273;&#7873;u làm 2 l&#7847;n. T&#7893;ng
li&#7873;u không v&#432;&#7907;t quá 2 g m&#7895;i ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Trong &#273;i&#7873;u tr&#7883; viêm màng não, li&#7873;u
kh&#7903;i &#273;&#7847;u là 100 mg/kg (không quá 4 g). Sau &#273;ó t&#7893;ng
li&#7873;u m&#7895;i ngày là 100 mg/kg/ngày, ngày tiêm 1 l&#7847;n. Th&#7901;i
gian &#273;i&#7873;u tr&#7883; th&#432;&#7901;ng t&#7915; 7 &#273;&#7871;n 14
ngày. Ð&#7889;i v&#7899;i nhi&#7877;m khu&#7849;n do <i>Streptococcus pyogenes</i>,
ph&#7843;i &#273;i&#7873;u tr&#7883; ít nh&#7845;t 10 ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Tr&#7867; s&#417; sinh</span></i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>: 50 mg/kg/ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt;mso-ansi-language:DE'>Suy th&#7853;n và suy gan ph&#7889;i
h&#7907;p: Ði&#7873;u ch&#7881;nh li&#7873;u d&#7921;a theo k&#7871;t qu&#7843;
ki&#7875;m tra các thông s&#7889; trong máu. Khi h&#7879; s&#7889; thanh th&#7843;i
creatinin d&#432;&#7899;i 10 ml/phút, li&#7873;u ceftriaxon không v&#432;&#7907;t
quá 2 g/24 gi&#7901;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>V&#7899;i ng&#432;&#7901;i b&#7879;nh th&#7849;m
phân máu, li&#7873;u 2 g tiêm cu&#7889;i &#273;&#7907;t th&#7849;m phân &#273;&#7911;
&#273;&#7875; duy trì n&#7891;ng &#273;&#7897; thu&#7889;c có hi&#7879;u l&#7921;c
cho t&#7899;i k&#7923; th&#7849;m phân sau, thông th&#432;&#7901;ng trong 72 gi&#7901;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Pha dung d&#7883;ch tiêm:<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Dung d&#7883;ch tiêm b&#7855;p: Hòa tan 0,25 g ho&#7863;c
0,5 g thu&#7889;c trong 2 ml và 1 g trong 3,5 ml dung d&#7883;ch lidocain 1%.
Không tiêm quá 1 g t&#7841;i cùng m&#7897;t v&#7883; trí. Không dùng dung d&#7883;ch
có ch&#7913;a lidocain &#273;&#7875; tiêm t&#297;nh m&#7841;ch.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Dung d&#7883;ch tiêm t&#297;nh m&#7841;ch: Hòa
tan 0,25 g ho&#7863;c 0,5 g thu&#7889;c trong 5 ml và 1 g trong 10 ml n&#432;&#7899;c
c&#7845;t vô khu&#7849;n. Th&#7901;i gian tiêm t&#7915; 2 - 4 phút. Tiêm tr&#7921;c
ti&#7871;p vào t&#297;nh m&#7841;ch ho&#7863;c qua dây truy&#7873;n dung d&#7883;ch.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Dung d&#7883;ch tiêm truy&#7873;n<i>:</i> Hòa tan
2 g b&#7897;t thu&#7889;c trong 40 ml dung d&#7883;ch tiêm truy&#7873;n không
có calci nh&#432;: natri clorid 0,9%, glucose 5%, glucose 10% ho&#7863;c natri
clorid và glucose (0,45% natri clorid và 2,5% glucose). Không dùng dung d&#7883;ch
Ringer lactat hòa tan thu&#7889;c &#273;&#7875; tiêm truy&#7873;n. Th&#7901;i
gian truy&#7873;n ít nh&#7845;t trong 30 phút. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Kh&#7843; n&#259;ng &#273;&#7897;c v&#7899;i th&#7853;n
c&#7911;a các cephalosporin có th&#7875; b&#7883; t&#259;ng b&#7903;i
gentamicin, colistin, furosemid.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Probenecid làm t&#259;ng n&#7891;ng &#273;&#7897;
c&#7911;a thu&#7889;c trong huy&#7871;t t&#432;&#417;ng do gi&#7843;m &#273;&#7897;
thanh th&#7843;i c&#7911;a th&#7853;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ð&#7897; &#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ceftriaxon b&#7897;t vô khu&#7849;n &#273;&#432;&#7907;c
b&#7843;o qu&#7843;n &#7903; nhi&#7879;t &#273;&#7897; phòng (25<sup>0</sup>C)
ho&#7863;c th&#7845;p h&#417;n và tránh ánh sáng. Nên dùng dung d&#7883;ch m&#7899;i
pha. Ð&#7897; b&#7873;n c&#7911;a dung d&#7883;ch thu&#7889;c ph&#7909; thu&#7897;c
vào n&#7891;ng &#273;&#7897; thu&#7889;c, dung môi pha, và nhi&#7879;t &#273;&#7897;
b&#7843;o qu&#7843;n. Dung d&#7883;ch pha &#273;&#7875; tiêm b&#7855;p b&#7873;n
v&#7919;ng trong 1 ngày &#7903; nhi&#7879;t &#273;&#7897; phòng (25<sup>0</sup>C)
và 3 ngày n&#7871;u &#273;&#7875; trong t&#7911; l&#7841;nh 4<sup>o</sup>C.
Dung d&#7883;ch tiêm t&#297;nh m&#7841;ch b&#7873;n trong 3 ngày &#7903; nhi&#7879;t
&#273;&#7897; phòng (25<sup>0</sup>C) và 10 ngày trong t&#7911; l&#7841;nh 4<sup>0</sup>C.
(Ho&#7841;t l&#7921;c thu&#7889;c gi&#7843;m d&#432;&#7899;i 10%).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Dây truy&#7873;n ho&#7863;c b&#417;m tiêm ph&#7843;i
&#273;&#432;&#7907;c tráng r&#7917;a c&#7849;n th&#7853;n b&#7857;ng n&#432;&#7899;c
mu&#7889;i (natri clorid 0,9%) gi&#7919;a các l&#7847;n tiêm ceftriaxon và các
thu&#7889;c khác nh&#432; vancomycin &#273;&#7875; tránh t&#7841;o t&#7911;a.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Không nên pha l&#7851;n ceftriaxon v&#7899;i các
dung d&#7883;ch thu&#7889;c kháng khu&#7849;n khác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ceftriaxon không &#273;&#432;&#7907;c pha v&#7899;i
các dung d&#7883;ch có ch&#7913;a calci và không &#273;&#432;&#7907;c pha l&#7851;n
v&#7899;i các aminoglycosid, amsacrin, vancomycin ho&#7863;c fluconazol.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Trong nh&#7919;ng tr&#432;&#7901;ng h&#7907;p quá
li&#7873;u, không th&#7875; làm gi&#7843;m n&#7891;ng &#273;&#7897; thu&#7889;c
b&#7857;ng th&#7849;m phân máu ho&#7863;c th&#7849;m phân màng b&#7909;ng.
Không có thu&#7889;c gi&#7843;i &#273;&#7897;c &#273;&#7863;c tr&#7883;, ch&#7911;
y&#7871;u là &#273;i&#7873;u tr&#7883; tri&#7879;u ch&#7913;ng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ceftriaxon có trong danh m&#7909;c thu&#7889;c
thi&#7871;t y&#7871;u Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432;
n&#259;m 1999.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thu&#7889;c ph&#7843;i &#273;&#432;&#7907;c kê &#273;&#417;n
và bán theo &#273;&#417;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Ceftriaxon.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:44 GMT -->
</html>
